Cargando…
Echoendoscopic ethanol ablation of tumor combined to celiac plexus neurolysis improved pain control in a patient with pancreatic adenocarcinoma
A 75-year-old man suffering from opioid-refractory due to an advanced pancreatic adenocarcinoma was treated with endoscopic ultrasound (EUS)-guided celiac plexus neurolysis (CPN) combined to EUS-guided tumor ablation. No major complications were recorded during the procedure. In the days following t...
Autores principales: | Facciorusso, Antonio, Maso, Marianna Di, Barone, Michele, Muscatiello, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672594/ https://www.ncbi.nlm.nih.gov/pubmed/26643704 http://dx.doi.org/10.4103/2303-9027.170428 |
Ejemplares similares
-
Sarcopenia represents a negative prognostic factor in pancreatic cancer patients undergoing EUS celiac plexus neurolysis
por: Facciorusso, Antonio, et al.
Publicado: (2020) -
Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac Plexus Neurolysis
por: Comlek, Savas
Publicado: (2020) -
Is Endoscopic Ultrasound-Guided Celiac Ganglia Neurolysis Superior to Celiac Plexus Neurolysis?
por: Paik, Woo Hyun, et al.
Publicado: (2013) -
Celiac plexus neurolysis for abdominal cancers: going beyond pancreatic cancer pain
por: Ambai, Vats T., et al.
Publicado: (2021) -
Celiac plexus neurolysis for the treatment of upper abdominal cancer pain
por: Teixeira, Manoel Jacobsen, et al.
Publicado: (2013)